Michael Hastings, 33, has died in a car crash in Los Angeles, according to reports. The author of wartime books and articles that included a candid profile of Gen. Stanley McChrystal is seen here at an event last year.
Journalist Michael Hastings Dies In Car Crash At Age 33
()The journalist whose candid interviews of Gen. Stanley McChrystal led to the officer's eventual removal from his post has died in a car crash, according to reports.
Google Files First-Amendment Request With FISA Court
Last week, Google asked the government to let it publish data about national security requests.
()Education
Home-Schooled Students Fight To Play On Public School Teams()
Roughly half of U.S. states have passed laws making home-schooled students eligible to play for their local school teams. But in Indiana, an attempt to find a middle ground hasn't calmed the debate.
The Two-Way
Perk Backlash: Do Surprise Upgrades Make Us Uneasy?()
When we get free perks we didn't earn, negative feelings can result, according to researchers. Part of the problem? Fellow customers. It helps if they're not around, a new study says.
Shots - Health News
Patients Lead The Way As Medicine Grapples With Apps()
WBURSmartphone apps can help count calories or detect a heart attack. People are embracing them to manage many aspects of their health. But medical apps are largely unregulated now, so there's no easy way to be sure which ones are trustworthy and which ones aren't.
It's All Politics
Obama's Unplanned NSA Discussion()
President Obama didn't expect he'd need to have a "national conversation" about government data-gathering.
The Two-Way
'Days Of Rambo Are Over': Pentagon Details Women's Move To Combat()
The U.S. military said in January that it will end its front-line combat exclusion for women; the shift means that women could join elite forces such as the Army Rangers and Navy SEALs in the next three years.
Shots - Health News
FDA Backs Off On Regulation Of Fecal Transplants()
Fecal transplants are being used more often to treat life-threatening bacterial infections. But the Food and Drug Administration worried that the still-experimental procedure put patients at risk. Now it is dropping plans to restrict transplants after doctors and patients complained.



